Health Catalyst, Inc., a top healthcare data and analytics company listed on the Nasdaq under the ticker HCAT, has announced the appointment of Ben Albert as President and Chief Operating Officer. Albert previously worked as CEO and co-founder of Upfront Healthcare Services until the company was acquired by Health Catalyst earlier this year, and he has remained in a leadership role. With more than 25 years of experience in building healthcare organizations focused on improving patient engagement and achieving strong clinical, financial, and operational outcomes, Albert brings a wealth of knowledge to his new position.
Health Technology Insights: Termeer Institute Appoints Catharine Smith as Chief Executive Officer
As President and COO, Albert will be responsible for managing the day-to-day operations and leading key departments such as Product Engineering, Technology Delivery and Support, Growth, Operations, Finance, and Corporate Strategy. He will work closely with current CEO Dan Burton, who plans to step down in June 2026. The company’s board believes this leadership structure will provide stability and consistency as the search for a new CEO continues. Meanwhile, Burton will continue to focus on maintaining strong relationships with investors and expanding the customer base during this transition period.
Dan LeSueur, who has served as COO, will transition to a part-time advisory role to support Albert and the company during this time of change. Burton expressed his enthusiasm about Albert joining the leadership team and highlighted his proven ability to lead mission-driven technology companies that deliver real value in healthcare. Burton also stressed that Albert’s leadership will be essential as Health Catalyst works toward its goal of making significant, measurable improvements in healthcare.
Health Technology Insights: GE HealthCare to Distribute Flyrcado via CDL Nuclear Tech
Jack Kane, Chair of the Health Catalyst Board, praised Albert’s appointment, stating it will help the company grow faster and increase shareholder value by building on its strengths in healthcare expertise and innovative technology. Kane also thanked LeSueur and Burton for their important contributions to the company.
Albert expressed his gratitude for the opportunity to lead and reaffirmed his commitment to driving long-term success for Health Catalyst’s clients. He emphasized that the company’s strong strategy, clear goals, and dedicated team are key assets for the future. Burton also recognized LeSueur’s 15 years of loyal leadership and the lasting impact he has had on the organization, wishing him well in his next endeavors. LeSueur reflected on his time at Health Catalyst with pride and confidence in the team’s talents and mission-driven mindset. He stated that Albert’s leadership will position the company for continued success in advancing healthcare improvement. This leadership change marks a significant step for Health Catalyst as it continues to develop and build on its legacy of improving healthcare outcomes through advanced data and analytics.
Health Technology Insights: SOPHiA GENETICS, Jessa Ziekenhuis Partner on Cancer Care
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
